secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-TECHNE Corp (TECH)
CIK:        0000842023
Form:       8-K
Filed at:   2024-05-01T23:59:59+00:00
Accession:  0001558370-24-006319
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Techne Q3 FY2024: Revenue $303.4M (+2% organic); GAAP EPS $0.31 vs $0.43; declares $0.08 dividend
--------------------------------------------------------------------------------

- Q3 revenue $303.4M (organic +2%, reported +3%); GAAP EPS $0.31 vs $0.43; adjusted EPS $0.48 vs $0.53.
- Diagnostics & Genomics segment organic growth 10% (reported 16%); record GMP reagent sales in cell/gene therapy.
- Cash from operations $223.5M, up 31% YoY.
- Quarterly dividend of $0.08 per share, payable May 24, 2024; record date May 13, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/842023/000155837024006319/0001558370-24-006319-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/842023/000155837024006319/tmb-20240501x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-006319

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer